Nicholas Tatonetti, PhD, Vice Chair of Computational Biomedicine at Cedars-Sinai (image credit)
What You Should Know
– Cedars-Sinai has secured a $5.05M ARPA-H contract to build KronosRx, an AI platform that predicts drug toxicity by pairing…
Continue Reading
Converge Bio Team
What You Should Know
– Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
– Moving beyond the “AI promise” gap, the…
Continue Reading
Thomas Kluz, Managing Partner at Niterra Ventures
Venture capital is making a comeback in healthcare, and this time, artificial intelligence (AI) is at the center of the movement.
According to Crunchbase, funding for AI-powered health-tech startups…
Continue Reading
What You Should Know
– Headlamp Health has launched Lumos AI, an analytical decision-support layer specifically engineered to solve the “Complexity Gap” in neuroscience drug development.
– Unlike tools focused on trial logistics, Lumos AI utilizes…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is David Bates, Founder and CEO at Linus Health. I talk with David…
Continue Reading
What You Should Know:
– Chai Discovery has secured a $130M Series B financing round, propelling its valuation to $1.3 billion just months after emerging from stealth.
– Co-led by Oak HC/FT and General Catalyst, the…
Continue Reading
What You Should Know:
– Valinor has launched with $13M in seed funding to tackle one of the pharmaceutical industry’s most expensive challenges: clinical trial failure led by CRV and Harpoon Ventures.
– The company uses…
Continue Reading
What You Should Know:
– Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes “agentic AI” and its proprietary…
Continue Reading
What You Should Know:
– PathAI has secured a historic regulatory milestone with the FDA qualification of its AIM-MASH AI Assist tool, making it the first AI-powered pathology biomarker to receive such status under the…
Continue Reading
What You Should Know:
– Weave Bio, the leader in AI-native regulatory automation, today announced the launch of HAQ Manager, a breakthrough capability that applies artificial intelligence (AI) and workflow automation to accelerate responses to…
Continue Reading
